Single oral administration of dronabinol increases ocular blood flow in patients with glaucoma
Acta Ophthalmologica · 2026-03 · 104 (2) · 225-232
DOI: 10.1111/aos.17573 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Acta Ophthalmologica, online erschienen am 07.08.2025. Verfasst von Theresa Lindner und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Dronabinol, Intraocular Pressure, Glaucoma, Open-Angle, Regional Blood Flow. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund.
Abstract (Originalsprache)
Purpose
Glaucoma is a leading cause of irreversible blindness globally, primarily driven by elevated intraocular pressure (IOP). Still, some patients progress despite significant IOP lowering, potentially due to impaired ocular blood flow. This study aimed to evaluate the effects of dronabinol, a synthetic tetrahydrocannabinol derivative, on ocular blood flow in primary open‐angle glaucoma (POAG) patients.
Methods
This randomized, double‐masked, placebo‐controlled, cross‐over study included 23 patients with treated POAG (mean age 68 ± 7 years). All participants received dronabinol (11 patients received 5 mg and 12 received 10 mg in a randomized fashion) on one study day and placebo on the other study day. The primary outcome was optic nerve head blood flow (ONHBF) measured by laser speckle flowgraphy. Mean blur rate was determined for the large vessel area (MV), the tissue area (MT) and the total ONH area (MA). Secondary outcomes included vessel densities assessed by optical coherence tomography angiography, IOP, and blood pressure.
Results
Administration of 10 mg dronabinol significantly increased ONHBF (MA: 10.8 ± 20.6%, p = 0.018, MV: 12.0 ± 24.8%, p = 0.042, and MT: 11.0 ± 22.6%, p = 0.022, each vs. placebo) up to 4 h post‐administration without affecting IOP or mean arterial pressure ( p > 0.548 each). Additionally, a significant increase in vessel density in the superficial vascular plexus was found after administration of 10 mg dronabinol (6.7 ± 14.7%, p = 0.040 vs. 5 mg).
Conclusion
This pilot study demonstrates that systemic dronabinol enhances ONHBF in glaucoma patients, suggesting its potential as adjunct therapy for glaucoma by targeting vascular dysfunction. Further longitudinal studies are needed to explore its long‐term impact on disease progression and visual field preservation. Trial Registration ClinicalTrials.gov ID: NCT04596826.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
- VIROS - Vienna Institute for Research in Ocular Surgery - Karl Landsteiner Institute, Hanusch Hospital, Vienna, Austria.
- Hommer Ophthalmology Institute, Vienna, Austria.
- Department of Child and Adolescent Psychiatry, Medical University of Vienna, Vienna, Austria.
- Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore.
- Ophthalmology and Visual Sciences Academic Clinical Program, Duke-NUS Medical School, Singapore, Singapore.
ORCID-Profile: Theresa Lindner, Viktoria Pai, Leopold Schmetterer, Gerhard Garhöfer, Doreen Schmidl
Förderung
- Austrian Science Fund
Zitieren
APA
Lindner, T., Pai, V., Janku, P., Hommer, N., Hommer, A., Abensperg-Traun, M., Petric, L., Schmetterer, L., Garhöfer, G., & Schmidl, D. (2026). Single oral administration of dronabinol increases ocular blood flow in patients with glaucoma. Acta Ophthalmologica, 104(2), 225-232. https://doi.org/10.1111/aos.17573
Vancouver
Lindner T, Pai V, Janku P, Hommer N, Hommer A, Abensperg-Traun M, et al. Single oral administration of dronabinol increases ocular blood flow in patients with glaucoma. Acta Ophthalmologica. 2026;104(2):225-232. doi:10.1111/aos.17573
BibTeX
@article{Lindner2026,
author = {Lindner, Theresa and Pai, Viktoria and Janku, Patrick and Hommer, Nikolaus and Hommer, Anton and Abensperg-Traun, Marihan and Petric, Liudmyla and Schmetterer, Leopold and Garhöfer, Gerhard and Schmidl, Doreen},
title = {Single oral administration of dronabinol increases ocular blood flow in patients with glaucoma},
journal = {Acta Ophthalmologica},
year = {2026},
volume = {104},
number = {2},
pages = {225--232},
doi = {10.1111/aos.17573}
}
EUVIMED